File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Delayed epistaxis in external dacryocystorhinostomy rate and risk factors

TitleDelayed epistaxis in external dacryocystorhinostomy rate and risk factors
Authors
Issue Date2010
PublisherAmerican Medical Association. The Journal's web site is located at http://www.archoto.com
Citation
Archives Of Otolaryngology - Head And Neck Surgery, 2010, v. 136 n. 2, p. 183-186 How to Cite?
AbstractObjective: To report the incidence and risk factors associated with delayed epistaxis (2-8 days after the procedure) after external dacryocystorhinostomy (DCR). Design: We identified and analyzed all cases of patients who underwent external DCR procedures at 2 institutions from January 1999 through December 2005. Cases of delayed epistaxis and their final surgical outcome were compared with those without it. Setting: All patients who underwent surgery and were examined at 2 public hospitals in Melbourne, Australia. Patients: A total of 374 patients who underwent 437 DCRs. Interventions: Medical treatment, hospitalization, and endonasal examination with cautery. Main Outcome Measures: Rate of delayed epistaxis and current and past use of antiplatelet medications. Results: Of the 374 patients (mean [SD] age, 62 [18] years; 280 [75%] were women) who underwent 437 external DCRs, 15 (3.4%) had an episode of delayed epistaxis. They were generally older and more likely to have a history of active dacryocystitis compared with those who did not develop delayed epistaxis. Preoperative use of aspirin, nonsteroidal anti-inflammatory drugs, or warfarin sodium was not associated with delayed epistaxis or poorer surgical outcome if these anticoagulants were discontinued preoperatively as instructed. None of the 15 patients with delayed epistaxis had continued ingesting anticoagulants before undergoing DCR. Patientswhodeveloped epistaxis (80%) had a significantly lower rate of satisfactory surgical outcome than those who did not (90%) (P=.02). Conclusion: The risk of delayed epistaxis should be similar for patients taking or not taking anticoagulant agents if their use is stopped within a defined period of time before DCR. ©2010 American Medical Association. All rights reserved.
Persistent Identifierhttp://hdl.handle.net/10722/183586
ISSN
2014 Impact Factor: 2.327
References

 

DC FieldValueLanguage
dc.contributor.authorSimon, GJBen_US
dc.contributor.authorCheung, Nen_US
dc.contributor.authorMcnab, AAen_US
dc.date.accessioned2013-05-28T06:15:01Z-
dc.date.available2013-05-28T06:15:01Z-
dc.date.issued2010en_US
dc.identifier.citationArchives Of Otolaryngology - Head And Neck Surgery, 2010, v. 136 n. 2, p. 183-186en_US
dc.identifier.issn0886-4470en_US
dc.identifier.urihttp://hdl.handle.net/10722/183586-
dc.description.abstractObjective: To report the incidence and risk factors associated with delayed epistaxis (2-8 days after the procedure) after external dacryocystorhinostomy (DCR). Design: We identified and analyzed all cases of patients who underwent external DCR procedures at 2 institutions from January 1999 through December 2005. Cases of delayed epistaxis and their final surgical outcome were compared with those without it. Setting: All patients who underwent surgery and were examined at 2 public hospitals in Melbourne, Australia. Patients: A total of 374 patients who underwent 437 DCRs. Interventions: Medical treatment, hospitalization, and endonasal examination with cautery. Main Outcome Measures: Rate of delayed epistaxis and current and past use of antiplatelet medications. Results: Of the 374 patients (mean [SD] age, 62 [18] years; 280 [75%] were women) who underwent 437 external DCRs, 15 (3.4%) had an episode of delayed epistaxis. They were generally older and more likely to have a history of active dacryocystitis compared with those who did not develop delayed epistaxis. Preoperative use of aspirin, nonsteroidal anti-inflammatory drugs, or warfarin sodium was not associated with delayed epistaxis or poorer surgical outcome if these anticoagulants were discontinued preoperatively as instructed. None of the 15 patients with delayed epistaxis had continued ingesting anticoagulants before undergoing DCR. Patientswhodeveloped epistaxis (80%) had a significantly lower rate of satisfactory surgical outcome than those who did not (90%) (P=.02). Conclusion: The risk of delayed epistaxis should be similar for patients taking or not taking anticoagulant agents if their use is stopped within a defined period of time before DCR. ©2010 American Medical Association. All rights reserved.en_US
dc.languageengen_US
dc.publisherAmerican Medical Association. The Journal's web site is located at http://www.archoto.comen_US
dc.relation.ispartofArchives of Otolaryngology - Head and Neck Surgeryen_US
dc.subject.meshAdulten_US
dc.subject.meshAgeden_US
dc.subject.meshAged, 80 And Overen_US
dc.subject.meshAnticoagulants - Adverse Effectsen_US
dc.subject.meshDacryocystorhinostomy - Adverse Effects - Methodsen_US
dc.subject.meshEpistaxis - Epidemiology - Etiologyen_US
dc.subject.meshFemaleen_US
dc.subject.meshHumansen_US
dc.subject.meshIncidenceen_US
dc.subject.meshLacrimal Duct Obstruction - Surgeryen_US
dc.subject.meshMaleen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshRetrospective Studiesen_US
dc.subject.meshRisk Factorsen_US
dc.subject.meshTime Factorsen_US
dc.titleDelayed epistaxis in external dacryocystorhinostomy rate and risk factorsen_US
dc.typeArticleen_US
dc.identifier.emailCheung, N: dannycheung@hotmail.comen_US
dc.identifier.authorityCheung, N=rp01752en_US
dc.description.naturelink_to_subscribed_fulltexten_US
dc.identifier.doi10.1001/archoto.2009.200en_US
dc.identifier.pmid20157067-
dc.identifier.scopuseid_2-s2.0-77149157861en_US
dc.relation.referenceshttp://www.scopus.com/mlt/select.url?eid=2-s2.0-77149157861&selection=ref&src=s&origin=recordpageen_US
dc.identifier.volume136en_US
dc.identifier.issue2en_US
dc.identifier.spage183en_US
dc.identifier.epage186en_US
dc.publisher.placeUnited Statesen_US
dc.identifier.scopusauthoridSimon, GJB=8954101900en_US
dc.identifier.scopusauthoridCheung, N=8054683900en_US
dc.identifier.scopusauthoridMcNab, AA=7005498604en_US

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats